179 related articles for article (PubMed ID: 6290715)
1. Immune response to alien histocompatibility antigens on Epstein-Barr virus transformed cells.
Mori T; Koishi T; Fujii G; Ohsawa N
Jpn J Exp Med; 1982 Jun; 52(3):125-9. PubMed ID: 6290715
[TBL] [Abstract][Full Text] [Related]
2. In vitro induction of HLA-restricted cytotoxic T lymphocytes against autologous Epstein-Barr Virus transformed B lymphoblastoid cell line.
Fukukawa T; Hirano T; Sakaguchi N; Teranishi T; Tsuyuguchi I; Nagao N; Naito N; Yoshimura K; Okubo Y; Tohda H; Oikawa A
J Immunol; 1981 May; 126(5):1697-701. PubMed ID: 6163815
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of allogeneic restriction of human cytotoxic T cell clones specific for Epstein Barr virus.
Tanaka Y; Sugamura K; Hinuma Y
J Immunol; 1982 Mar; 128(3):1241-5. PubMed ID: 6173428
[TBL] [Abstract][Full Text] [Related]
4. The Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines (LCL) as stimulating cells in mixed lymphocyte culture (MLC).
Wasik M; Matej H; Duś D; Myc A
Arch Immunol Ther Exp (Warsz); 1983; 31(6):879-85. PubMed ID: 6331341
[TBL] [Abstract][Full Text] [Related]
5. Memory of Epstein-Barr virus-specific cytotoxic T cells in normal seropostive adults as revealed by an in vitro restimulation method.
Tanaka Y; Sugamura K; Hinuma Y; Sato H; Okochi K
J Immunol; 1980 Oct; 125(4):1426-31. PubMed ID: 6157733
[TBL] [Abstract][Full Text] [Related]
6. Sensitization of lymphocytes against pooled allogeneic cells. II. Characterization of effector cells cytotoxic for autologous lymphoblastoid cell lines.
Zarling JM; Bach FH; Kung PC
J Immunol; 1981 Jan; 126(1):375-8. PubMed ID: 6450239
[TBL] [Abstract][Full Text] [Related]
7. Establishment of human cytotoxic T cell lines specific for human adult T cell leukemia virus-bearing cells.
Kannagi M; Sugamura K; Sato H; Okochi K; Uchino H; Hinuma Y
J Immunol; 1983 Jun; 130(6):2942-6. PubMed ID: 6189906
[TBL] [Abstract][Full Text] [Related]
8. HLA-D typing using Epstein-Barr virus-induced lymphoblastoid cell lines.
Akiyama N; Ohsawa N; Samaru Y; Kusaba R
Jpn J Exp Med; 1982 Apr; 52(2):67-73. PubMed ID: 6288983
[TBL] [Abstract][Full Text] [Related]
9. Stimulation with autologous lymphoblastoid cell lines: lysis of Epstein-Barr virus-positive and -negative cell lines by two phenotypically distinguishable effector cell populations.
Zarling JM; Dierckins MS; Sevenich EA; Clouse KA
J Immunol; 1981 Nov; 127(5):2118-23. PubMed ID: 6170690
[TBL] [Abstract][Full Text] [Related]
10. Two distinct human cloned T cell lines that exhibit natural killer-like and anti-human effector activities.
Sugamura K; Tanaka Y; Hinuma Y
J Immunol; 1982 Apr; 128(4):1749-52. PubMed ID: 6120975
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-induced lymphoblastoid cell lines from seropositive adult donors and their HLA-antigens.
Akiyama N; Ohsawa N; Kusaba R; Inou T; Takada M
Jpn J Exp Med; 1981 Feb; 51(1):1-7. PubMed ID: 6273617
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of lymphocytes by allogeneic lymphocytes and lymphoblasts in the presence of anti-HLA antisera.
Corley RB; Dawson JR; Amos DB
Eur J Immunol; 1976 Apr; 6(4):235-40. PubMed ID: 186270
[TBL] [Abstract][Full Text] [Related]
13. Establishment and characterization of Epstein-Barr virus-specific human CD4+ T lymphocyte clones.
Honda S; Takasaki T; Okuno K; Yasutomi M; Kurane I
Acta Virol; 1998 Nov; 42(5):307-13. PubMed ID: 10358731
[TBL] [Abstract][Full Text] [Related]
14. Sensitization of lymphocytes against pooled allogeneic cells. I. Generation of cytotoxicity against autologous human lymphoblastoid cell lines.
Zarling JM; Bach FH
J Exp Med; 1978 May; 147(5):1334-40. PubMed ID: 206649
[TBL] [Abstract][Full Text] [Related]
15. Immunologic cytotoxicity against autologous human lymphocytes transformed or infected by Epstein-Bar virus: role of antibody-dependent cellular cytotoxicity in health individuals.
Aya T; Mizuno F; Osato T
J Natl Cancer Inst; 1980 Aug; 65(2):265-71. PubMed ID: 6249949
[TBL] [Abstract][Full Text] [Related]
16. Gene-modified spontaneous Epstein-Barr virus-transformed lymphoblastoid cell lines as autologous cancer vaccines: mutated p21 ras oncogene as a model.
Kubuschok B; Cochlovius C; Jung W; Schmits R; Trümper L; Hartmann F; Renner C; Pfreundschuh M
Cancer Gene Ther; 2000 Sep; 7(9):1231-40. PubMed ID: 11023195
[TBL] [Abstract][Full Text] [Related]
17. Functional CD4(+) and CD8(+) T-cell responses induced by autologous mitomycin C treated Epstein-Barr virus transformed lymphoblastoid cell lines.
Meij P; Bloemena E; Palmen N; Brink A; Vervoort MB; Meijer CJ; Middeldorp JM
Cell Immunol; 2001 Feb; 208(1):25-33. PubMed ID: 11277616
[TBL] [Abstract][Full Text] [Related]
18. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures.
Hurrell SM; Zarling JM
J Immunol; 1983 Aug; 131(2):1017-23. PubMed ID: 6223084
[TBL] [Abstract][Full Text] [Related]
19. Assessment and characterization of the cytolytic T lymphocyte response against Epstein-Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation.
Nolte A; Buhmann R; Straka C; Emmerich B; Hallek M
Bone Marrow Transplant; 1998 May; 21(9):909-16. PubMed ID: 9613783
[TBL] [Abstract][Full Text] [Related]
20. T lymphocyte culture established by repeated stimulation with the autologous lymphoblastoid line. MHC class II restricted interactions with B blasts.
Torsteinsdottir S; Masucci MG; Szigeti R; Bishara A; Brautbar C; Klein G; Klein E
Mol Biol Med; 1984 Aug; 2(4):285-99. PubMed ID: 6443579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
